Menu
Back to Journals » Neuropsychiatric Disease and Treatment » Volume 18
Neuropsychiatric Disease and Treatment
ISSN: 1178-2021
- View all (4085)
- Volume 19, 2023 (228)
- Volume 18, 2022 (272)
- Volume 17, 2021 (351)
- Volume 16, 2020 (325)
- Volume 15, 2019 (353)
- Volume 14, 2018 (354)
- Volume 13, 2017 (333)
- Volume 12, 2016 (367)
- Volume 11, 2015 (340)
- Volume 10, 2014 (275)
- Volume 9, 2013 (223)
- Volume 8, 2012 (74)
- Volume 7, 2011 (87)
- Volume 6, 2010 (90)
- Volume 5, 2009 (65)
- Volume 4, 2008 (128)
- Volume 3, 2007 (105)
- Volume 2, 2006 (70)
- Volume 1, 2005 (45)
Archive: Volume 18, 2022
- default (272)
- Cariprazine in schizophrenia (5)
- Issues and Solutions in Autism Spectrum Disorders (ASD) (9)
- Current Perspectives of Chronic Stress: from Neurobiology to Treatment (3)
Biological Diagnosis of Depression: A Biomarker Panel from Several Nonspecial Indicators Instead of the Specific Biomarker(s)
Li JM, Jiang CL
Neuropsychiatric Disease and Treatment 2022, 18:3067-3071
Published Date: 30 December 2022
Age of Diagnosis and Demographic Factors Associated with Autism Spectrum Disorders in Chinese Children: A Multi-Center Survey
Long D, Yang T, Chen J, Dai Y, Chen L, Jia F, Wu L, Hao Y, Li L, Zhang J, Ke X, Yi M, Hong Q, Chen J, Fang S, Wang Y, Wang Q, Jin C, Li T
Neuropsychiatric Disease and Treatment 2022, 18:3055-3065
Published Date: 30 December 2022
Family Functioning is Associated with Post-Stroke Depression in First-Ever Stroke Survivors: A Longitudinal Study
Wang X, Hu CX, Lin MQ, Liu SY, Zhu FY, Wan LH
Neuropsychiatric Disease and Treatment 2022, 18:3045-3054
Published Date: 29 December 2022
Analysis of Demographic and Clinical Characteristics of Patients with Dissociative Identity Disorder
Atilan Fedai Ü, Asoğlu M
Neuropsychiatric Disease and Treatment 2022, 18:3035-3044
Published Date: 28 December 2022
Alexithymia and Parental Bonding in Women with Genitopelvic Pain/Penetration Disorder
Ozdemir YO, Ergelen M, Ozen B, Akgul IF, Bestepe EE
Neuropsychiatric Disease and Treatment 2022, 18:3023-3033
Published Date: 23 December 2022
Myasthenia Gravis and Lambert-Eaton Myasthenic Syndrome: New Developments in Diagnosis and Treatment
Pascuzzi RM, Bodkin CL
Neuropsychiatric Disease and Treatment 2022, 18:3001-3022
Published Date: 22 December 2022
Gender Difference in Cognitive Function Among Stable Schizophrenia: A Network Perspective
Chen M, Zhang L, Jiang Q
Neuropsychiatric Disease and Treatment 2022, 18:2991-3000
Published Date: 22 December 2022
Higher Neutrophil to Lymphocyte Ratio at Admission is Association with Post-PCI Depressive Symptoms in Patients with ACS
Li C, Wan S, Li W, Wang Y, Li B, Chen Y, Sun P, Lyu J
Neuropsychiatric Disease and Treatment 2022, 18:2981-2990
Published Date: 22 December 2022
Impact of the COVID-19 Pandemic on Medication Adherence and Maintenance Treatment for Schizophrenia: A Reconsideration [Letter]
Oguchi Y
Neuropsychiatric Disease and Treatment 2022, 18:2979-2980
Published Date: 22 December 2022
Alterations of Regional Homogeneity in Parkinson’s Disease with Rapid Eye Movement Sleep Behavior Disorder
Jiang X, Pan Y, Zhu S, Wang Y, Gu R, Jiang Y, Shen B, Zhu J, Xu S, Yan J, Dong J, Zhang W, Xiao C, Zhang L
Neuropsychiatric Disease and Treatment 2022, 18:2967-2978
Published Date: 19 December 2022
Activation of the RMTg Nucleus by Chemogenetic Techniques Alleviates the Learning and Memory Impairment in APP/PS1 Mice
Zheng L, Wang Z, Liu Y, Zhao J, Huang S
Neuropsychiatric Disease and Treatment 2022, 18:2957-2965
Published Date: 20 December 2022
Clinician Perceptions of the Negative Impact of Telehealth Services in the Management of Drug-Induced Movement Disorders and Opportunities for Quality Improvement: A 2021 Internet-Based Survey
Bera R, Bron M, Benning B, Cicero S, Calara H, Darling D, Franey E, Martello K, Yonan C
Neuropsychiatric Disease and Treatment 2022, 18:2945-2955
Published Date: 19 December 2022
Treatment-Resistant Bipolar Depression: Therapeutic Trends, Challenges and Future Directions
Elsayed OH, Ercis M, Pahwa M, Singh B
Neuropsychiatric Disease and Treatment 2022, 18:2927-2943
Published Date: 16 December 2022
Biopsychology of Physical Activity in People with Schizophrenia: An Integrative Perspective on Barriers and Intervention Strategies
Arnautovska U, Kesby JP, Korman N, Rebar AL, Chapman J, Warren N, Rossell SL, Dark FL, Siskind D
Neuropsychiatric Disease and Treatment 2022, 18:2917-2926
Published Date: 15 December 2022
Fecal Microbiota Transplantation in Autism Spectrum Disorder
Li Y, Wang Y, Zhang T
Neuropsychiatric Disease and Treatment 2022, 18:2905-2915
Published Date: 15 December 2022
Knowledge Atlas of Insular Epilepsy: A Bibliometric Analysis
Li M, Ma X, Mai C, Fan Z, Wang Y, Ren Y
Neuropsychiatric Disease and Treatment 2022, 18:2891-2903
Published Date: 14 December 2022
The Relationship Between Negative Life Events and Nonsuicidal Self-Injury Among Chinese Adolescents: A Moderated-Mediation Model
Zhang Y, Suo X, Zhang Y, Zhang S, Yang M, Qian L, Shang L, Zhang D, Xu F, Li W
Neuropsychiatric Disease and Treatment 2022, 18:2881-2890
Published Date: 14 December 2022
Recognizing Depression in the Elderly: Practical Guidance and Challenges for Clinical Management
Devita M, De Salvo R, Ravelli A, De Rui M, Coin A, Sergi G, Mapelli D
Neuropsychiatric Disease and Treatment 2022, 18:2867-2880
Published Date: 7 December 2022
Efficacy and Safety of Esketamine Combined with Antidepressants for Treatment-Resistant Depression: A Meta-Analysis
Liu P, Zhang SS, Liang Y, Gao ZJ, Gao W, Dong BH
Neuropsychiatric Disease and Treatment 2022, 18:2855-2865
Published Date: 7 December 2022
An Exploration of Smoking Patterns Among People with Serious Mental Illness Attending an Outpatient Clinic in Qatar
Zolezzi M, Al-Rawi S, Eltorki Y
Neuropsychiatric Disease and Treatment 2022, 18:2847-2854
Published Date: 7 December 2022
Homocysteine and Clinical Outcomes in Intracerebral Hemorrhage Patients: Results from the China Stroke Center Alliance
Wang D, Cao Z, Li Z, Gu H, Zhou Q, Zhao X, Wang Y
Neuropsychiatric Disease and Treatment 2022, 18:2837-2846
Published Date: 7 December 2022
Rett Syndrome and MECP2 Duplication Syndrome: Disorders of MeCP2 Dosage
Collins BE, Neul JL
Neuropsychiatric Disease and Treatment 2022, 18:2813-2835
Published Date: 29 November 2022
Major Depression and Onset of Frontotemporal Dementia
Urban-Kowalczyk M, Kasjaniuk M, Śmigielski J, Kotlicka-Antczak M
Neuropsychiatric Disease and Treatment 2022, 18:2807-2812
Published Date: 29 November 2022
Behavioral Activation Therapy for Subthreshold Depression in Stroke Patients: An Exploratory Randomized Controlled Trial
Sun Q, Xu H, Zhang W, Zhou Y, Lv Y
Neuropsychiatric Disease and Treatment 2022, 18:2795-2805
Published Date: 29 November 2022
Depression and Cognitive Impairment: Current Understanding of Its Neurobiology and Diagnosis
Wen M, Dong Z, Zhang L, Li B, Zhang Y, Li K
Neuropsychiatric Disease and Treatment 2022, 18:2783-2794
Published Date: 29 November 2022
Effect of Personality Traits on Sustained Remission Among Patients with Major Depression: A 12-Month Prospective Study
Nogami W, Nakagawa A, Katayama N, Kudo Y, Amano M, Ihara S, Kurata C, Kobayashi Y, Sasaki Y, Ishikawa N, Sato Y, Mimura M
Neuropsychiatric Disease and Treatment 2022, 18:2771-2781
Published Date: 28 November 2022
Cognitive Dysfunction and Its Risk Factors in Patients Undergoing Maintenance Hemodialysis
Tian X, Xia X, Yu H, Chen H, Jiang A, Xin L
Neuropsychiatric Disease and Treatment 2022, 18:2759-2769
Published Date: 24 November 2022
A Southeast Asia Consensus on the Definition and Management of Treatment-Resistant Depression
Tor PC, Amir N, Fam J, Ho R, Ittasakul P, Maramis MM, Ponio B, Purnama DA, Rattanasumawong W, Rondain E, Bin Sulaiman AH, Wiroteurairuang K, Chee KY
Neuropsychiatric Disease and Treatment 2022, 18:2747-2757
Published Date: 22 November 2022
Post-Thrombolytic D-Dimer Elevation Predicts Symptomatic Intracranial Hemorrhage and Poor Functional Outcome After Intravenous Thrombolysis in Acute Ischemic Stroke Patients
Jin T, Chen D, Chen Z, Feng D, Zheng M, Wang P, Xu C
Neuropsychiatric Disease and Treatment 2022, 18:2737-2745
Published Date: 22 November 2022
Characteristics of Attention-Deficit/Hyperactivity Disorder Subtypes in Children Classified Using Quantitative Electroencephalography
Ji Y, Choi TY, Lee J, Yoon S, Won GH, Jeong H, Kang SW, Kim JW
Neuropsychiatric Disease and Treatment 2022, 18:2725-2736
Published Date: 21 November 2022
Early Versus Late Tracheostomy in Stroke Patients: A Retrospective Analysis
Shen Y, Cao Q, Zhuo H, Hu M, Chen S
Neuropsychiatric Disease and Treatment 2022, 18:2713-2723
Published Date: 17 November 2022
Changes in Mood, Anxiety, and Cognition with Polycystic Ovary Syndrome Treatment: A Longitudinal, Naturalistic Study
Sukhapure M, Eggleston K, Fenton A, Frampton C, Porter RJ, Douglas KM
Neuropsychiatric Disease and Treatment 2022, 18:2703-2712
Published Date: 15 November 2022
Orexin/Hypocretin System Dysfunction in ESSENCE (Early Symptomatic Syndromes Eliciting Neurodevelopmental Clinical Examinations)
Knez R, Stevanovic D, Fernell E, Gillberg C
Neuropsychiatric Disease and Treatment 2022, 18:2683-2702
Published Date: 15 November 2022
Individuals with Bipolar Disorder Have a Higher Level of Homocysteine Than Major Depressive Disorder: A Retrospective Chart Review and Observational Study
Zhao M, Liu T, Qi S, Li W, Liu X, Li X, Xun G
Neuropsychiatric Disease and Treatment 2022, 18:2671-2682
Published Date: 15 November 2022
Study on the Changes in Circadian Rhythm Before and After Treatment and the Influencing Factors in Patients with Depression
Guo P, Fang Y, Feng M, Shen Y, Yang S, Wang S, Qian M
Neuropsychiatric Disease and Treatment 2022, 18:2661-2669
Published Date: 10 November 2022
Altered Cerebral Blood Flow is Linked to Disease Duration in Patients with Generalized tonic‒clonic Seizures
Li T, Niu S, Qiu X, Zhai Z, Yang L, Chen L, Zhang XM
Neuropsychiatric Disease and Treatment 2022, 18:2649-2659
Published Date: 10 November 2022
Depression, Diabetes Mellitus and Mortality in Older Adults: A National Cohort Study in Taiwan
Chen VCH, Wang TN, Hsieh MC, Chou SY, Lee MC, McIntyre RS, Lu ML, Liao YT, Yeh CJ
Neuropsychiatric Disease and Treatment 2022, 18:2639-2648
Published Date: 10 November 2022
Effectiveness of Lurasidone 80 mg in Patients with Schizophrenia: Results of an Open-Label, 12-Week Extension Study
Miura I, Watabe K, Sakaguchi R, Okamoto K, Maruyama H
Neuropsychiatric Disease and Treatment 2022, 18:2627-2637
Published Date: 9 November 2022
Mindfulness Meditation Interventions for Long COVID: Biobehavioral Gene Expression and Neuroimmune Functioning
Porter N, Jason LA
Neuropsychiatric Disease and Treatment 2022, 18:2599-2626
Published Date: 8 November 2022
Association Between the Number of Remaining Teeth and Body Mass Index in Japanese Inpatients with Schizophrenia
Otake M, Ono S, Watanabe Y, Kumagai K, Matsuzawa K, Kasahara H, Ootake M, Sugai T, Someya T
Neuropsychiatric Disease and Treatment 2022, 18:2591-2597
Published Date: 7 November 2022
Computed Tomography, Magnetic Resonance Imaging, and Pathological Features of Gliosarcoma
Fan H, Yu Y, Du J, Liu L, Luo Y, Yu H, Liao X
Neuropsychiatric Disease and Treatment 2022, 18:2577-2589
Published Date: 4 November 2022
Protective Role of Astrocyte-Derived Exosomal microRNA-361 in Cerebral Ischemic-Reperfusion Injury by Regulating the AMPK/mTOR Signaling Pathway and Targeting CTSB [Retraction]
Bu X, Li D, Wang F, Sun Q, Zhang Z
Neuropsychiatric Disease and Treatment 2022, 18:2575-2576
Published Date: 3 November 2022
The ESSENCE-Questionnaire in Medical Records Screening for Neurodevelopmental Symptoms/Problems: Utility and Clinical Validity
Landgren V, Raanan Soltis Z, Svensson E, Theodosiou M, Landgren M, Knez R
Neuropsychiatric Disease and Treatment 2022, 18:2559-2574
Published Date: 3 November 2022
Can Fluoxetine Combined with Cognitive Behavioral Therapy Reduce the Suicide and Non-Suicidal Self-Injury Incidence and Recurrence Rate in Depressed Adolescents Compared with Fluoxetine Alone? A Meta-Analysis
Liu W, Li G, Wang C, Yu M, Zhu M, Yang L
Neuropsychiatric Disease and Treatment 2022, 18:2543-2557
Published Date: 2 November 2022
Serum Soluble Scavenger Receptor A Levels are Associated with Delayed Cerebral Ischemia and Poor Clinical Outcome After Aneurysmal Subarachnoid Hemorrhage: A Prospective Observational Study
Jiang F, Chen Z, Hu J, Liu Q
Neuropsychiatric Disease and Treatment 2022, 18:2529-2541
Published Date: 2 November 2022
Serum NOX1 and Raftlin as New Potential Biomarkers of Interest in Schizophrenia: A Preliminary Study
Hurşitoğlu O, Kurutas EB, Strawbridge R, Uygur OF, Yildiz E, Reilly TJ
Neuropsychiatric Disease and Treatment 2022, 18:2519-2527
Published Date: 2 November 2022
Validation and Functional Relevance of the Short Form of the Perceived Deficits Questionnaire for Depression for Japanese Patients with Major Depressive Disorder
Sumiyoshi T, Uchida H, Watanabe K, Oosawa M, Ren H, Moriguchi Y, Fujikawa K, Fernandez J
Neuropsychiatric Disease and Treatment 2022, 18:2507-2517
Published Date: 2 November 2022
In vivo Characterization of the Opioid Receptor–Binding Profiles of Samidorphan and Naltrexone in Rats: Comparisons at Clinically Relevant Concentrations
Tan LA, Gajipara N, Sun L, Bacolod M, Zhou Y, Namchuk M, Cunningham JI
Neuropsychiatric Disease and Treatment 2022, 18:2497-2506
Published Date: 1 November 2022
KXS Balances the Tryptophan Metabolism in Mild to Moderate Depressed Patients and Chronic Restraint Stress Induced Depressive Rats
Wang Y, Li X, Jing R, Yang W, Wang Y, Wang C, Yao L, Cui X, Hu Y
Neuropsychiatric Disease and Treatment 2022, 18:2485-2496
Published Date: 1 November 2022
Electroconvulsive Therapy Practice in Thailand: A Nationwide Survey
Kittayarak K, Ittasakul P
Neuropsychiatric Disease and Treatment 2022, 18:2477-2484
Published Date: 31 October 2022
Measuring Response to Adjunctive Therapy Among Individuals with Major Depressive Disorder
Forma F, Liberman JN, Rui P, Wiggins E, Ruetsch C
Neuropsychiatric Disease and Treatment 2022, 18:2467-2475
Published Date: 28 October 2022
Mitochondrial Damage of Lymphocytes in Patients with Acute Relapse of Schizophrenia: A Correlational Study with Efficacy and Clinical Symptoms
Hu A, Li F, Guo L, Zhao X, Xiang X
Neuropsychiatric Disease and Treatment 2022, 18:2455-2466
Published Date: 27 October 2022
Bevacizumab for the Treatment of High-Grade Meningiomas: Is There New Evidence? [Letter]
da Silva VTG, Gebrin T, Paiva WS
Neuropsychiatric Disease and Treatment 2022, 18:2453-2454
Published Date: 27 October 2022
An Evidence-Based Nursing Intervention Decreases Anxiety, Depression, Sleep Quality and Somatic Symptoms of Patients with Acute Ischemic Stroke
Gao WJ, Bao WJ, Sun SJ
Neuropsychiatric Disease and Treatment 2022, 18:2443-2451
Published Date: 25 October 2022
Implications of Seizure-Cluster Treatment on Healthcare Utilization: Use of Approved Rescue Medications
Rabinowicz AL, Faught E, Cook DF, Carrazana E
Neuropsychiatric Disease and Treatment 2022, 18:2431-2441
Published Date: 25 October 2022
Associations between Internet Addiction, Psychiatric Comorbidity, and Maternal Depression and Anxiety in Clinically Referred Children and Adolescents
Sakamoto S, Miyawaki D, Goto A, Hirai K, Hama H, Kadono S, Nishiura S, Inoue K
Neuropsychiatric Disease and Treatment 2022, 18:2421-2430
Published Date: 21 October 2022
How Accurately Does the Information on Motor Development Collected During Health Checkups for Infants Predict the Diagnosis of Neurodevelopmental Disorders? – A Bayesian Network Model-Based Study
Hatakenaka Y, Hachiya K, Ikezoe S, Åsberg Johnels J, Gillberg C
Neuropsychiatric Disease and Treatment 2022, 18:2405-2420
Published Date: 19 October 2022
Blood and CSF Homocysteine Levels in Alzheimer’s Disease: A Meta-Analysis and Meta-Regression of Case–Control Studies
Zhang L, Xie X, Sun Y, Zhou F
Neuropsychiatric Disease and Treatment 2022, 18:2391-2403
Published Date: 17 October 2022
Recent Advances of Telepractice for Autism Spectrum Disorders in Speech and Language Pathology
Christopoulou M, Drosos K, Petinou K
Neuropsychiatric Disease and Treatment 2022, 18:2379-2389
Published Date: 14 October 2022
Language and Speech Characteristics in Autism
Vogindroukas I, Stankova M, Chelas EN, Proedrou A
Neuropsychiatric Disease and Treatment 2022, 18:2367-2377
Published Date: 14 October 2022
Rehabilitation Services for Young Adults with ASD
Kristofik A, Johnson KL
Neuropsychiatric Disease and Treatment 2022, 18:2361-2366
Published Date: 17 October 2022
Comparing Theory of Mind Development in Children with Autism Spectrum Disorder, Developmental Language Disorder, and Typical Development
Schwartz Offek E, Segal O
Neuropsychiatric Disease and Treatment 2022, 18:2349-2359
Published Date: 14 October 2022
Detecting Time Concept Competence in Children with Autism Spectrum and Attention Disorders
Hus Y
Neuropsychiatric Disease and Treatment 2022, 18:2323-2348
Published Date: 14 October 2022
Feeding and Swallowing Issues in Autism Spectrum Disorders
Adams SN
Neuropsychiatric Disease and Treatment 2022, 18:2311-2321
Published Date: 14 October 2022
The Efficacy of Head-Mounted-Display Virtual Reality Intervention to Improve Life Skills of Individuals with Autism Spectrum Disorders: A Systematic Review
Skjoldborg NM, Bender PK, Jensen de López KM
Neuropsychiatric Disease and Treatment 2022, 18:2295-2310
Published Date: 17 October 2022
Nature and Effects of Autobiographical Memory Issues in Persons with Autism Spectrum Disorders
Westby C
Neuropsychiatric Disease and Treatment 2022, 18:2279-2293
Published Date: 17 October 2022
Focus on Issues and Solutions in Autism Spectrum Disorders (ASD)
Petinou K, Hus Y, Segal O
Neuropsychiatric Disease and Treatment 2022, 18:2273-2277
Published Date: 17 October 2022
Prognostic Value of the Neutrophil-to-Lymphocyte Ratio in Patients with Chronic Internal Carotid Artery Occlusion Complicated by Cerebral Infarction
Qiu Z, Guo T, Sheng X, Tang Y, Du H
Neuropsychiatric Disease and Treatment 2022, 18:2265-2271
Published Date: 14 October 2022
Advances in the Treatment of Dysphagia in Neurological Disorders: A Review of Current Evidence and Future Considerations
Cheng I, Hamad A, Sasegbon A, Hamdy S
Neuropsychiatric Disease and Treatment 2022, 18:2251-2263
Published Date: 14 October 2022
Posttraumatic Stress Disorder, Suicidal Behavior, Substance Use, and Sexual Victimization Among Adolescent Girls Aged 10-19 Years Living Under Ethnic-Based Civil War in Ethiopia
Wolde A, Dessalegn N
Neuropsychiatric Disease and Treatment 2022, 18:2239-2250
Published Date: 11 October 2022
HIV, HSV, SARS-CoV-2 and Ebola Share Long-Term Neuropsychiatric Sequelae
Büttiker P, Stefano GB, Weissenberger S, Ptacek R, Anders M, Raboch J, Kream RM
Neuropsychiatric Disease and Treatment 2022, 18:2229-2237
Published Date: 5 October 2022
Uric Acid and Clinical Outcomes in Young Patients with Ischemic Stroke
Liu Y, Liu X, Jia J, Guo J, Li G, Zhao X
Neuropsychiatric Disease and Treatment 2022, 18:2219-2228
Published Date: 29 September 2022
Genetic Polymorphism of NQO1 Gene is Associated with Susceptibility of Ischemic Stroke in Chinese Han Nationality
Yan L, Xu D, Xiao Y, Dai M, Wang T, Zhuang X, Wu K
Neuropsychiatric Disease and Treatment 2022, 18:2211-2217
Published Date: 28 September 2022
Plasma SIRT3 as a Biomarker of Severity and Prognosis After Acute Intracerebral Hemorrhage: A Prospective Cohort Study
Yan T, Wang ZF, Wu XY, Du Q, Yu WH, Hu W, Zheng YK, Wang KY, Dong XQ
Neuropsychiatric Disease and Treatment 2022, 18:2199-2210
Published Date: 26 September 2022
Ketogenic Diet Alleviates Hippocampal Neurodegeneration Possibly via ASIC1a and the Mitochondria-Mediated Apoptotic Pathway in a Rat Model of Temporal Lobe Epilepsy
Qiao Q, Qu Z, Tian S, Cao H, Zhang Y, Sun C, Jia L, Wang W
Neuropsychiatric Disease and Treatment 2022, 18:2181-2198
Published Date: 25 September 2022
Preliminary Study of Vagus Nerve Magnetic Modulation in Patients with Prolonged Disorders of Consciousness
Wang L, Wu Q, Yang Z, Yang Y, Luo Y, Cao Y, Wu L, Xie Y, Wang Y
Neuropsychiatric Disease and Treatment 2022, 18:2171-2179
Published Date: 25 September 2022
COMT Val158Met Polymorphism Influences the Cerebral Blood Flow Changes Related to Psychomotor Retardation in Major Depressive Disorder
Yin Y, Xie C, Zhang H, Zhang H, Zhang Z, Yuan Y
Neuropsychiatric Disease and Treatment 2022, 18:2159-2169
Published Date: 25 September 2022
The Performance of Visual, Auditory, and Motor Cognitive Flexibility for Children with Autism Spectrum Disorder in Taiwan
Lin CL, Shen CP, Lin CK
Neuropsychiatric Disease and Treatment 2022, 18:2151-2158
Published Date: 23 September 2022
A Long Duration of Reflux Symptoms is the Predominant Risk Factor for Depression in Vietnamese Patients with Gastroesophageal Reflux Disease
Quach DT, Phan BT
Neuropsychiatric Disease and Treatment 2022, 18:2141-2150
Published Date: 23 September 2022
Application Value of Serum Metabolic Markers for Cognitive Prediction in Elderly Epilepsy
Wei H, Liu D, Geng L, Liu Y, Wang H, Yan F
Neuropsychiatric Disease and Treatment 2022, 18:2133-2140
Published Date: 22 September 2022
Management of Functional Seizures and Functional Movement Disorder: A Cross-Sectional Comparative Study
Dal Pasquale BG, Teive HAG, Heyde MDVD, Dal Pasquale LFA
Neuropsychiatric Disease and Treatment 2022, 18:2121-2131
Published Date: 21 September 2022
Knowledge Atlas of the Co-Occurrence of Epilepsy and Autism: A Bibliometric Analysis and Visualization Using VOSviewer and CiteSpace
Wang Y, Huo X, Li W, Xiao L, Li M, Wang C, Sun Y, Sun T
Neuropsychiatric Disease and Treatment 2022, 18:2107-2119
Published Date: 19 September 2022
Transcutaneous Vagus Nerve Stimulation Combined with Rehabilitation Training in the Intervention of Upper Limb Movement Disorders After Stroke: A Systematic Review
Yan L, Qian Y, Li H
Neuropsychiatric Disease and Treatment 2022, 18:2095-2106
Published Date: 16 September 2022
Provider Perspectives on the Current Use of Lithium Medications and Lithium Monitoring Practices for Psychiatric Conditions
Parkin GM, Thomas EA
Neuropsychiatric Disease and Treatment 2022, 18:2083-2093
Published Date: 15 September 2022
Cerebral, Psychosocial, Family Functioning and Disability of Persons with Schizophrenia
Valencia M, Medina R, Calixto E, Rodríguez N
Neuropsychiatric Disease and Treatment 2022, 18:2069-2082
Published Date: 15 September 2022
The ESSENCE-Questionnaire for Neurodevelopmental Problems – A Swedish School-Based Validation Study in 11-Year-Old Children
Landgren V, Svensson L, Knez R, Theodosiou M, Gillberg C, Fernell E, Landgren M, Johnson M
Neuropsychiatric Disease and Treatment 2022, 18:2055-2067
Published Date: 15 September 2022
Differences in mGluR5 Availability Depending on the Level of Social Avoidance in Drug-Naïve Young Patients with Major Depressive Disorder
Kim JH, Joo YH, Son YD, Kim HK, Kim JH
Neuropsychiatric Disease and Treatment 2022, 18:2041-2053
Published Date: 12 September 2022
Serum Uric Acid to Serum Creatinine Ratio and Risk of Stroke Recurrence in Young Adults with Ischemic Stroke
Sun X, Lv J, Wu Z, Shi J, Huang H
Neuropsychiatric Disease and Treatment 2022, 18:2031-2039
Published Date: 9 September 2022
Liver Fibrosis is Associated with Clinical Outcomes in Patients with Intracerebral Hemorrhage
Wang J, Bian L, Wang A, Zhang X, Wang D, Jiang R, Wang W, Ju Y, Lu J, Zhao X
Neuropsychiatric Disease and Treatment 2022, 18:2021-2030
Published Date: 8 September 2022
Impact of COVID-19 Pandemic on Prescribing of Long-Acting Injectable Antipsychotics for Schizophrenia: Results from a United States Prescriber Survey
Zhdanava M, Starr HL, Totev TI, Lefebvre P, Shah A, Sheng K, Pilon D
Neuropsychiatric Disease and Treatment 2022, 18:2003-2019
Published Date: 7 September 2022
Predictors of Early Neurological Deterioration and Functional Outcome in Acute Ischemic Stroke: The Importance of Large Artery Disease, Hyperglycemia and Inflammatory Blood Biomarkers
Sabir Rashid A, Huang-Link Y, Johnsson M, Wetterhäll S, Gauffin H
Neuropsychiatric Disease and Treatment 2022, 18:1993-2002
Published Date: 6 September 2022
Sensitivity and Specificity of Central Vein Sign as a Diagnostic Biomarker in Egyptian Patients with Multiple Sclerosis
Abdel Ghany H, Karam-Allah A, Edward R, Abdel Naseer M, Hegazy MI
Neuropsychiatric Disease and Treatment 2022, 18:1985-1992
Published Date: 1 September 2022
Depression and Associated Risk Factors Among Type 2 Diabetic Patients: A Cross Sectional Study on a Convenience Sample from the Diabetic Center, Khamis Mushait; Saudi Arabia
Abuhegazy H, Mujairi A, Banah F, Agdi Y, Elkeshishi H, Kamel A, Abdullah A, Elsheikh M
Neuropsychiatric Disease and Treatment 2022, 18:1975-1984
Published Date: 31 August 2022
Effectiveness of Vortioxetine in Patients with Major Depressive Disorder in Real-World Clinical Practice: French Cohort Results from the Global RELIEVE Study
Polosan M, Rabbani M, Christensen MC, Simonsen K, Ren H
Neuropsychiatric Disease and Treatment 2022, 18:1963-1974
Published Date: 31 August 2022
New-Onset Refractory Status Epilepticus Secondary to COVID-19 Infection in Adults: A Systematic Review
Arif A, Chavarria Y, Qamar MA, Tebha SS, Butt M, Qamar K, Yosufi A
Neuropsychiatric Disease and Treatment 2022, 18:1951-1961
Published Date: 30 August 2022
Effectiveness and Safety of Vortioxetine for Major Depressive Disorder in Real-World Clinical Practice: Results from the Single-Arm RELIEVE China Study
Wang G, Xiao L, Ren H, Simonsen K, Ma J, Xu X, Guo P, Wang Z, Bai L, Heldbo Reines E, Hammer-Helmich L
Neuropsychiatric Disease and Treatment 2022, 18:1939-1950
Published Date: 30 August 2022
Comparing Relapse Rates in Real-World Patients with Schizophrenia Who Were Adequately versus Not Adequately Treated with Paliperidone Palmitate Once-Monthly Injections Before Transitioning to Once-Every-3-Months Injections
Turkoz I, Daskiran M, Starr HL, Najarian D, Lopena O, Obando C, Keenan A, Benson C, Gopal S
Neuropsychiatric Disease and Treatment 2022, 18:1927-1937
Published Date: 30 August 2022
Relationship Between Depression After Hemorrhagic Stroke and Auditory Event-Related Potentials in a Chinese Patient Group
Wen QH, Liu Y, Chen HD, Wu JL, Liang LJ, He WZ, Wang Y, Huang GP
Neuropsychiatric Disease and Treatment 2022, 18:1917-1925
Published Date: 30 August 2022
Acute Ischemic Stroke in the Context of SARS-CoV-2 Vaccination: A Systematic Review
Rahmig J, Altarsha E, Siepmann T, Barlinn K
Neuropsychiatric Disease and Treatment 2022, 18:1907-1916
Published Date: 30 August 2022
Acupuncture Treatment is Associated with Reduced Dementia Risk in Patients with Migraine: A Propensity-Score–Matched Cohort Study of Real-World Data
Huang CH, Lin MC, Chou IC, Hsieh CL
Neuropsychiatric Disease and Treatment 2022, 18:1895-1906
Published Date: 30 August 2022
Intranasal Administration of Brain-Derived Neurotrophic Factor Rescues Depressive-Like Phenotypes in Chronic Unpredictable Mild Stress Mice
Li XL, Liu H, Liu SH, Cheng Y, Xie GJ
Neuropsychiatric Disease and Treatment 2022, 18:1885-1894
Published Date: 29 August 2022
Radiological Features for Outcomes of MOGAD in Children: A Cohort in Southwest China
Fan X, Li Q, Li T, He X, Feng C, Qin B, Xu Y, He L
Neuropsychiatric Disease and Treatment 2022, 18:1875-1884
Published Date: 26 August 2022
Study on Biomarkers Related to the Treatment of Post-Stroke Depression and Alternative Medical Treatment Methods
Li M, Ding R, Yang X, Ran D
Neuropsychiatric Disease and Treatment 2022, 18:1861-1873
Published Date: 26 August 2022
The Association of IL7R rs6897932 with Risk of Multiple Sclerosis in Southern Chinese
Zhao Z, Xue J, Zhuo Z, Zhong W, Liu H
Neuropsychiatric Disease and Treatment 2022, 18:1855-1859
Published Date: 26 August 2022
Alleviating Excessive Worries Improves Co-Occurring Depression and Pain in Adolescent and Young Adult Cancer Patients: A Network Approach
Li W, Xu Y, Luo X, Wen Y, Ding K, Xu W, Garg S, Yang Y, Sun H
Neuropsychiatric Disease and Treatment 2022, 18:1843-1854
Published Date: 25 August 2022
Association Plasma Aβ42 Levels with Alzheimer’s Disease and Its Influencing Factors in Chinese Elderly Population
Wu Y, Wang Z, Yin J, Yang B, Fan J, Cheng Z
Neuropsychiatric Disease and Treatment 2022, 18:1831-1841
Published Date: 24 August 2022
Psychological Interventions on Abstinence in Patients with Alcohol Use Disorder: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials
Zhang P, Zhan J, Wang S, Tang Y, Chen H, Wang Y, Wei X, Wen H, Pan T, Chen Z, Tang C, Xu N, Lu L
Neuropsychiatric Disease and Treatment 2022, 18:1815-1830
Published Date: 23 August 2022
Combining Multiple Indices of Diffusion Tensor Imaging Can Better Differentiate Patients with Traumatic Brain Injury from Healthy Subjects
Abdelrahman HAF, Ubukata S, Ueda K, Fujimoto G, Oishi N, Aso T, Murai T
Neuropsychiatric Disease and Treatment 2022, 18:1801-1814
Published Date: 23 August 2022
Motor Functional Characteristics in Attention-Deficit/Hyperactivity Disorder and Autism Spectrum Disorders: A Systematic Review [Corrigendum]
Takagi S, Hori H, Yamaguchi T, Ochi S, Nishida M, Maruo T, Takahashi H
Neuropsychiatric Disease and Treatment 2022, 18:1799-1800
Published Date: 23 August 2022
Psychometric Properties of the Montreal Cognitive Assessment (MoCA) to Detect Major Neurocognitive Disorder Among Older People in Ethiopia: A Validation Study
Daniel B, Agenagnew L, Workicho A, Abera M
Neuropsychiatric Disease and Treatment 2022, 18:1789-1798
Published Date: 22 August 2022
Malnutrition and the Risk of Early Neurological Deterioration in Elderly Patients with Acute Ischemic Stroke
Bao Y, Zhang Y, Du C, Ji Y, Dai Y, Jiang W
Neuropsychiatric Disease and Treatment 2022, 18:1779-1787
Published Date: 20 August 2022
Association Between High-Sensitivity C-Reactive Protein and Prognosis of Patients with Acute Cerebral Infarction
Pu Y, Li S, Wang L, Fang B, Bai X
Neuropsychiatric Disease and Treatment 2022, 18:1771-1778
Published Date: 20 August 2022
Downregulation of miR-210 Promoted Apoptosis of Hippocampal Neurons by Negatively Regulating the TLR4/NF-кB1 Signaling Pathway in a Rat Model of Status Epilepticus
Zhou Q, Luo H, Wang X, Li P, Kong H, He B
Neuropsychiatric Disease and Treatment 2022, 18:1763-1770
Published Date: 18 August 2022
Moderating and Mediating Effects of Resilience Together with Neuroticism on Depressive Symptoms in Adult Volunteers
Ito S, Morishita C, Masuya J, Ono M, Honyashiki M, Higashi S, Tamada Y, Fujimura Y, Inoue T
Neuropsychiatric Disease and Treatment 2022, 18:1751-1761
Published Date: 17 August 2022
Psychological Disturbances and Their Association with Sleep Disturbance in Patients Admitted for Arrhythmia Diseases
Hu LX, Tang M, Hua W, Ren XQ, Jia YH, Chu JM, Zhang JT, Liu XN
Neuropsychiatric Disease and Treatment 2022, 18:1739-1750
Published Date: 17 August 2022
The Experience Among College Students with Social Anxiety Disorder in Social Situations: A Qualitative Study
Luan YS, Zhan-ling G, Mi L, Ying L, Lan B, Tong L
Neuropsychiatric Disease and Treatment 2022, 18:1729-1737
Published Date: 15 August 2022
Continuous Intravenous versus Subcutaneous Administration of Insulin for Glycemic Variability in Acute Ischemic Stroke [Corrigendum]
Du LZ, Liu PY, Ge CY, Li Y, Li YY, Tang MF, Chen JJ
Neuropsychiatric Disease and Treatment 2022, 18:1727-1728
Published Date: 15 August 2022
Chronic Stress in Bipolar Disorders Across the Different Clinical States: Roles of HPA Axis and Personality
Zhang M, Zhao S, Chen Y, Zhang X, Li Y, Xu P, Huang Y, Sun X
Neuropsychiatric Disease and Treatment 2022, 18:1715-1725
Published Date: 12 August 2022
Efficacy and Safety of Low-Dose Brexpiprazole for Acute Schizophrenia: Meta-Analysis of Randomized Placebo-Controlled Trials
Zhao M, Qin B, Mao Y, Wang H, Wang A, Wang C
Neuropsychiatric Disease and Treatment 2022, 18:1705-1713
Published Date: 11 August 2022
CACNA1C Gene rs1006737 Polymorphism Affects Cognitive Performance in Chinese Han Schizophrenia
Chen M, Jiang Q, Zhang L
Neuropsychiatric Disease and Treatment 2022, 18:1697-1704
Published Date: 10 August 2022
Motor Functional Characteristics in Attention-Deficit/Hyperactivity Disorder and Autism Spectrum Disorders: A Systematic Review
Takagi S, Hori H, Yamaguchi T, Ochi S, Nishida M, Maruo T, Takahashi H
Neuropsychiatric Disease and Treatment 2022, 18:1679-1695
Published Date: 9 August 2022
Effectiveness of Vortioxetine in Patients with Major Depressive Disorder in Real-World Clinical Practice in Italy: Results from the RELIEVE Study
De Filippis S, Pugliese A, Christensen MC, Rosso G, Di Nicola M, Simonsen K, Ren H
Neuropsychiatric Disease and Treatment 2022, 18:1665-1677
Published Date: 9 August 2022
Relative Safety and Efficacy of Two Doses of Tandospirone Citrate for Generalized Anxiety Disorder: A Multicenter Randomized Controlled Trial
Li Q, Zhang H, Lin G, Shi S, Zhang Y, Ji J, Yang L, Yao J, Wu W
Neuropsychiatric Disease and Treatment 2022, 18:1653-1664
Published Date: 8 August 2022
One-Year Clinical Outcomes Following Electroconvulsive Therapy for Patients with Schizophrenia: A Nationwide Health Insurance Data-Based Study
Joo SW, Kim H, Jo YT, Ahn S, Choi YJ, Choi W, Park S, Lee J
Neuropsychiatric Disease and Treatment 2022, 18:1645-1652
Published Date: 8 August 2022
Pharmacological Management of Core Symptoms and Comorbidities of Autism Spectrum Disorder in Children and Adolescents: A Systematic Review
Maniram J, Karrim SBS, Oosthuizen F, Wiafe E
Neuropsychiatric Disease and Treatment 2022, 18:1629-1644
Published Date: 7 August 2022
Efficacy of Bevacizumab in High-Grade Meningiomas: A Retrospective Clinical Study
Bai X, Liu X, Wen J
Neuropsychiatric Disease and Treatment 2022, 18:1619-1627
Published Date: 6 August 2022
Evaluating Opicapone as Add-on Treatment to Levodopa/DDCI in Patients with Parkinson’s Disease
Jost WH
Neuropsychiatric Disease and Treatment 2022, 18:1603-1618
Published Date: 6 August 2022
Clinical Features in Parkinson’s Disease Patients with Hyperechogenicity in Substantia Nigra: A Cross-Sectional Study
Zhu S, Wang Y, Jiang Y, Gu R, Zhong M, Jiang X, Shen B, Zhu J, Yan J, Pan Y, Zhang L
Neuropsychiatric Disease and Treatment 2022, 18:1593-1601
Published Date: 2 August 2022
Preliminary Findings on the Potential Use of Magnetic Resonance Elastography to Diagnose Lacunar Infarction
Wang L, Ke J, Hu X, Zhu M, Yu Y
Neuropsychiatric Disease and Treatment 2022, 18:1583-1591
Published Date: 1 August 2022
Short Sleep Duration as a Risk Factor for Depression, Anxiety and Fatigue in Patients with Leukemia
Huan Y, Mujun X, Xin L, Ping Z, Limei F, Aming L, Xinquan L
Neuropsychiatric Disease and Treatment 2022, 18:1573-1582
Published Date: 29 July 2022
Working Conditions, Work Productivity, Quality of Life, and Depressive Symptoms in Undiagnosed Adults with and without Attention-Deficit/Hyperactivity Disorder (ADHD) Symptoms During the COVID-19 Pandemic
Nakai T, Tsuji T, Tsuda H, Sotodate T, Namba Y, Uenishi T, Iwasaki K, Kokubo K, Tomita H
Neuropsychiatric Disease and Treatment 2022, 18:1561-1572
Published Date: 29 July 2022
Value of Serum Adiponectin Combined with ABCD2 in Predicting Cerebral Infarction Among Patients with Acute Isolated Vertigo
Qian S, Zhang X, Wang Y
Neuropsychiatric Disease and Treatment 2022, 18:1553-1559
Published Date: 29 July 2022
Gender Differences in Psychiatric Symptoms and the Social Functioning of 610 Patients with Schizophrenia in Urban China: A 10-Year Follow-Up Study
Zhao J, Diao J, Li X, Yang Y, Yao Y, Shi S, Yuan X, Liu H, Zhang K
Neuropsychiatric Disease and Treatment 2022, 18:1545-1551
Published Date: 27 July 2022
Role of Increased Syncytin-1 Expression in Pathogenesis of Anti-N-Methyl-d-Aspartate Receptor Encephalitis
Qiao S, Sun QY, Zhang SC, Zhang RR, Wu YJ, Wang ZH, Liu XW
Neuropsychiatric Disease and Treatment 2022, 18:1535-1543
Published Date: 29 July 2022
Healthcare Provider Engagement with a Novel Dashboard for Tracking Medication Ingestion: Impact on Treatment Decisions and Clinical Assessments for Adults with Schizophrenia
Cochran JM, Fang H, Sonnenberg JG, Cohen EA, Lindenmayer JP, Reuteman-Fowler JC
Neuropsychiatric Disease and Treatment 2022, 18:1521-1534
Published Date: 28 July 2022
The Role of Gut Microbiota in the Progression of Parkinson’s Disease and the Mechanism of Intervention by Traditional Chinese Medicine
Huan P, Wang L, He Z, He J
Neuropsychiatric Disease and Treatment 2022, 18:1507-1520
Published Date: 26 July 2022
The Relationship Between Patent Foramen Ovale and Unexplained Dizziness: A Prospective Analysis in China
Cao Q, Shen Y, Hou Z, Li D, Tang B, Xu L, Li Y
Neuropsychiatric Disease and Treatment 2022, 18:1495-1505
Published Date: 26 July 2022
Understanding the Health System Conditions Affecting the Use of Long-Acting Injectable Antipsychotics in the Treatment of Schizophrenia in Clinical Practice: A US Healthcare Provider Survey
Zhdanava M, Starr HL, Lefebvre P, Totev TI, Shah A, Sheng K, Pilon D
Neuropsychiatric Disease and Treatment 2022, 18:1479-1493
Published Date: 22 July 2022
Association Between Serum Uric Acid Levels and Suicide Attempts in Adolescents and Young Adults with Major Depressive Disorder: A Retrospective Study
Kong Y, Liu C, Zhang C, Wang W, Li Y, Qiu H, Wang G, Li D, Chen X, Lv Z, Zhou D, Wan L, Ai M, Chen J, Ran L, Kuang L
Neuropsychiatric Disease and Treatment 2022, 18:1469-1477
Published Date: 20 July 2022
Incidence of Postoperative Cognitive Dysfunction Following Inhalational vs Total Intravenous General Anesthesia: A Systematic Review and Meta-Analysis
Negrini D, Wu A, Oba A, Harnke B, Ciancio N, Krause M, Clavijo C, Al-Musawi M, Linhares T, Fernandez-Bustamante A, Schmidt S
Neuropsychiatric Disease and Treatment 2022, 18:1455-1467
Published Date: 15 July 2022
Utility of Serum Growth Arrest-Specific Protein 6 as a Biomarker of Severity and Prognosis After Severe Traumatic Brain Injury: A Prospective Observational Study
Ni BK, Cai JY, Wang XB, Lin Q, Zhang XN, Wu JH
Neuropsychiatric Disease and Treatment 2022, 18:1441-1453
Published Date: 14 July 2022
Switching Clozapine to Cariprazine in Three Patients with Persistent Symptoms of Schizophrenia: A Case Series
Duque-Yemail JD, Avila JC
Neuropsychiatric Disease and Treatment 2022, 18:1433-1440
Published Date: 13 July 2022
Cognitive Performance is Associated with Altered Cerebral Hemodynamics Assessed by Transcranial Ultrasound in Parkinson’s Disease
Ge YL, Gong SY, Wang PZ, Yan JH, Li W, Zhang JR, Jin H, Zhuang S, Hu L, Ding CW, Yang YP, Wang F, Li D, Chen J, Mao CJ, Zhang YC, Li K, Liu CF
Neuropsychiatric Disease and Treatment 2022, 18:1421-1431
Published Date: 12 July 2022
Magnitude of Depression and Associated Factors Among Patients on Tuberculosis Treatment at Public Health Facilities in Harari Regional State, Eastern Ethiopia: Multi-Center Cross-Sectional Study
Abdurahman S, Yadeta TA, Ayana DA, Kure MA, Ahmed J, Mehadi A
Neuropsychiatric Disease and Treatment 2022, 18:1405-1419
Published Date: 11 July 2022
The Predictive Value of Contrast-Enhanced Ultrasound Combined with Serum miR-124 Level in Acute Cerebral Infarction and Their Correlation with the Contrast Enhancement of Carotid Atherosclerotic Plaque
Zhao P, Xu E, Yuan R, Zhou R, Pan J
Neuropsychiatric Disease and Treatment 2022, 18:1397-1403
Published Date: 11 July 2022
Anhedonia in Depression and Schizophrenia: Brain Reward and Aversion Circuits
Liang S, Wu Y, Hanxiaoran L, Greenshaw AJ, Li T
Neuropsychiatric Disease and Treatment 2022, 18:1385-1396
Published Date: 7 July 2022
Effects of Acupuncture at Neiguan in Neural Activity of Related Brain Regions: A Resting-State fMRI Study in Anxiety
Li C, Wang Y, Li B, Su S
Neuropsychiatric Disease and Treatment 2022, 18:1375-1384
Published Date: 6 July 2022
Abnormal Degree Centrality in Children with Low-Function Autism Spectrum Disorders: A Sleeping-State Functional Magnetic Resonance Imaging Study
Xu S, Li M, Yang C, Fang X, Ye M, Wu Y, Yang B, Huang W, Li P, Ma X, Fu S, Yin Y, Tian J, Gan Y, Jiang G
Neuropsychiatric Disease and Treatment 2022, 18:1363-1374
Published Date: 5 July 2022
Cariprazine on Psychosis: Beyond Schizophrenia – A Case Series
Bajouco M, Mota D
Neuropsychiatric Disease and Treatment 2022, 18:1351-1362
Published Date: 5 July 2022
Development and Reliability Testing of the Stroke Patient Protection Motivation Scale
Han C, Zhang L, Liu J
Neuropsychiatric Disease and Treatment 2022, 18:1341-1349
Published Date: 4 July 2022
Brain-Reactive Antibodies are Potential Biomarkers for Evaluating Therapeutic Efficacy in NPSLE Patients
Wang X, Feng D, Ke Y, Gu L, Lv C, Zhang M, Wang Q, Wang Y
Neuropsychiatric Disease and Treatment 2022, 18:1329-1340
Published Date: 4 July 2022
Association Between Non-Suicidal Self-Injury and Gut Microbial Characteristics in Chinese Adolescent
Cai L, Wang S, Hou C, Li Z, Liao Y, Jia FJ
Neuropsychiatric Disease and Treatment 2022, 18:1315-1328
Published Date: 1 July 2022
Continuous Intravenous versus Subcutaneous Administration of Insulin for Glycemic Variability in Acute Ischemic Stroke
Du LZ, Liu PY, Ge CY, Li Y, Li YY, Tang MF, Chen JJ
Neuropsychiatric Disease and Treatment 2022, 18:1309-1314
Published Date: 1 July 2022
Mediating Effect of Self-Efficacy on the Relationship Between Perceived Social Support and Resilience in Patients with Recurrent Schizophrenia in China
Wang LY, Li MZ, Jiang XJ, Han Y, Liu J, Xiang TT, Zhu ZM
Neuropsychiatric Disease and Treatment 2022, 18:1299-1308
Published Date: 1 July 2022
Associations of High-Sensitivity C-Reactive Protein and Interleukin-6 with Depression in a Sample of Italian Adolescents During COVID-19 Pandemic
Serra M, Presicci A, Quaranta L, Achille M, Caputo E, Medicamento S, Margari F, Croce F, Margari L
Neuropsychiatric Disease and Treatment 2022, 18:1287-1297
Published Date: 29 June 2022
An Online Survey About Electroconvulsive Therapy in Japan During the COVID-19 Pandemic: Comparison of Early and Recent Stages
Hirata R, Kawashima H, Tsuboi T, Wada K, Takebayashi M, Suwa T
Neuropsychiatric Disease and Treatment 2022, 18:1277-1285
Published Date: 28 June 2022
Neurological Side Effects of SARS-CoV-2 Vaccinations are Not Uncommon but Frequently Ignored [Letter]
Finsterer J, Scorza FA
Neuropsychiatric Disease and Treatment 2022, 18:1273-1275
Published Date: 27 June 2022
Evaluation of α-Synuclein and Apolipoprotein E as Potential Biomarkers in Cerebrospinal Fluid to Monitor Pharmacotherapeutic Efficacy in Dopamine Dictated Disease States of Parkinson’s Disease and Schizophrenia [Corrigendum]
Gupta AK, Pokhriyal R, Das U, Khan MI, Ratna Kumar D, Gupta R, Chadda RK, Ramachandran R, Goyal V, Tripathi M, Hariprasad G
Neuropsychiatric Disease and Treatment 2022, 18:1271-1272
Published Date: 27 June 2022
Gait and Balance Disorder in Patients with Transient Ischemic Attack or Minor Stroke [Corrigendum]
Li N, Li J, Gao T, Wang D, Du Y, Zhao X
Neuropsychiatric Disease and Treatment 2022, 18:1269-1270
Published Date: 27 June 2022
Examining the Long-Term Sequelae of SARS-CoV2 Infection in Patients Seen in an Outpatient Psychiatric Department
Farooqi M, Khan A, Jacobs A, D’Souza V, Consiglio F, Karmen CL, Dornbush R, Hasnat GS, Ferrando SJ
Neuropsychiatric Disease and Treatment 2022, 18:1259-1268
Published Date: 21 June 2022
Resilience Moderates the Association of Sleep Disturbance and Sleep Reactivity with Depressive Symptoms in Adult Volunteers
Terao I, Masuya J, Morishita C, Higashiyama M, Shimura A, Tamada Y, Inoue T, Fujimura Y
Neuropsychiatric Disease and Treatment 2022, 18:1249-1257
Published Date: 20 June 2022
Pain Mimicking Trigeminal Neuralgia in Patients with Acute Ischemic Stroke of the Brainstem
Shi Y, Feng Z, Ju Y, Zhang Z
Neuropsychiatric Disease and Treatment 2022, 18:1237-1248
Published Date: 20 June 2022
Assessing the Capabilities of Transcranial Magnetic Stimulation (TMS) to Aid in the Removal of Brain Tumors Affecting the Motor Cortex: A Systematic Review
Schiavao LJV, Neville Ribeiro I, Yukie Hayashi C, Gadelha Figueiredo E, Russowsky Brunoni A, Jacobsen Teixeira M, Pokorny G, Silva Paiva W
Neuropsychiatric Disease and Treatment 2022, 18:1219-1235
Published Date: 16 June 2022
Tacrolimus Combined with Corticosteroids Improved the Outcome of CIDP Patients with Autoantibodies Against Paranodal Proteins
Yang M, Xu L, Ji S, Gao H, Zhang Q, Bu B
Neuropsychiatric Disease and Treatment 2022, 18:1207-1217
Published Date: 16 June 2022
Validation of the Romanian Version of the Social Media Addiction Scale-Student Form (SMAS-SF) Among Undergraduate Medical Students
Ursoniu S, Serban CL, Giurgi-Oncu C, Rivis IA, Bucur A, Papava I, Bredicean AC
Neuropsychiatric Disease and Treatment 2022, 18:1195-1205
Published Date: 15 June 2022
Vilazodone for Major Depression in Adults: Pharmacological Profile and an Updated Review for Clinical Practice
Chauhan M, Parry R, Bobo WV
Neuropsychiatric Disease and Treatment 2022, 18:1175-1193
Published Date: 14 June 2022
Effects of Washed Fecal Bacteria Transplantation in Sleep Quality, Stool Features and Autism Symptomatology: A Chinese Preliminary Observational Study
Zhang Y, Zhang J, Pan Z, He X
Neuropsychiatric Disease and Treatment 2022, 18:1165-1173
Published Date: 11 June 2022
Comorbidity Between Recent Diagnosis of Type 2 Diabetes and Non-Psychotic Psychiatric Disorders: Metabolic Characteristics and Clinical Correlates
Alcántara-Garcés MT, Rodríguez-Ramírez AM, García-Ulloa AC, Hernández-Jiménez S
Neuropsychiatric Disease and Treatment 2022, 18:1151-1163
Published Date: 12 June 2022
Using Cariprazine to Ameliorate Negative Symptoms and Metabolic Side Effects of Clozapine and Paliperidone – Clinical Cases
Viegas F, Ferreira T, Campos C
Neuropsychiatric Disease and Treatment 2022, 18:1145-1149
Published Date: 9 June 2022
The Incidence and Costs of Adverse Events Associated with Antidepressants: Results from a Systematic Review, Network Meta-Analysis and Multi-Country Economic Model
Kearns B, Cooper K, Orr M, Essat M, Hamilton J, Cantrell A
Neuropsychiatric Disease and Treatment 2022, 18:1133-1143
Published Date: 7 June 2022
Use of Clinical Global Impressions-Severity (CGI-S) to Assess Response to Antidepressant Treatment in Patients with Treatment-Resistant Depression
Morrens J, Mathews M, Popova V, Borentain S, Rive B, Gonzalez Martin Moro B, Jamieson C, Zhang Q
Neuropsychiatric Disease and Treatment 2022, 18:1127-1132
Published Date: 7 June 2022
Serum Sulfonylurea Receptor-1 Levels After Acute Supratentorial Intracerebral Hemorrhage: Implication for Prognosis
Zhuge CJ, Zhan CP, Wang KW, Yan XJ, Yu GF
Neuropsychiatric Disease and Treatment 2022, 18:1117-1126
Published Date: 3 June 2022
A Study of Spontaneous Brain Activity on Resting-State Functional Magnetic Resonance Imaging in Adults with MRI-Negative Temporal Lobe Epilepsy
Yang F, Jia W, Kukun H, Ding S, Zhang H, Wang Y
Neuropsychiatric Disease and Treatment 2022, 18:1107-1116
Published Date: 2 June 2022
Autoimmune Glial Fibrillary Acidic Protein Astrocytopathy: To Identify Its Diagnosis, Management and Prognosis (GFAP-AID) Registry: Study Protocol for an Ambispective, Multicenter Registry in China
Yang J, Jiang L, Yao H, Huang L, Long Y
Neuropsychiatric Disease and Treatment 2022, 18:1099-1105
Published Date: 1 June 2022
The Predictive Role of Aberrant Metabolic Parameters and Negative Automatic Thinking on the Cognitive Impairments Among Schizophrenia Patients with Metabolic Syndrome
Zhang X, He C, Ju P, Xia Q, Gao J, Zhang L, Chen X, Yuan H, Gao H, Zhang Y, Yan J, Xie W, Zhu C
Neuropsychiatric Disease and Treatment 2022, 18:1087-1097
Published Date: 7 June 2022
High Levels of D-Dimer are Associated with Poor Hospitalization Outcome of Spontaneous Intraparenchymal Haemorrhage
Chen X, Shi S, Hu L
Neuropsychiatric Disease and Treatment 2022, 18:1079-1086
Published Date: 30 May 2022
Prevalence and Predictors of Postpartum Depression Among Male Partners Who Came to Postnatal Follow-Up Clinic with Their Partner in Selected Public Health Centers of Wolaita Zone, Ethiopia, 2019 [Retraction]
Markos M, Arba A
Neuropsychiatric Disease and Treatment 2022, 18:1077-1078
Published Date: 27 May 2022
Characteristics of Patients with Meningeal Carcinomatosis Combined with Myelopathy
Jiao L, Wei M, Fu Y
Neuropsychiatric Disease and Treatment 2022, 18:1069-1075
Published Date: 19 May 2022
Atypical Treatment Switches in Schizophrenia Patients: Drivers and Associated Outcomes
Khandker R, Shepherd J, Chekani F, Qureshi Z, Bailey H, Berry M, Wright J, Massey L
Neuropsychiatric Disease and Treatment 2022, 18:1057-1067
Published Date: 18 May 2022
Epilepsy Stigma Among University Students in Makkah: A Cross-Sectional Study
Alkhotani AM, Alkhotani AM
Neuropsychiatric Disease and Treatment 2022, 18:1047-1056
Published Date: 17 May 2022
Association of Pain with Plasma C5a in Patients with Neuromyelitis Optica Spectrum Disorders During Remission
Tong Y, Liu J, Yang T, Wang J, Zhao T, Kang Y, Fan Y
Neuropsychiatric Disease and Treatment 2022, 18:1039-1046
Published Date: 17 May 2022
VRT-043198 Ameliorates Surgery-Induced Neurocognitive Disorders by Restoring the NGF and BNDF Expression in Aged Mice
Tang Q, Guo Q, Li K, Fei F
Neuropsychiatric Disease and Treatment 2022, 18:1027-1037
Published Date: 16 May 2022
Tenecteplase in Ischemic Stroke: Challenge and Opportunity
Li G, Wang C, Wang S, Xiong Y, Zhao X
Neuropsychiatric Disease and Treatment 2022, 18:1013-1026
Published Date: 11 May 2022
Minimal Effects of Cariprazine on Prolactin Levels in Bipolar Disorder and Schizophrenia
Culpepper L, Vieta E, Kelly DL, Patel MD, Szatmári B, Hankinson A, Earley WR
Neuropsychiatric Disease and Treatment 2022, 18:995-1011
Published Date: 12 May 2022
Association Between the Neutrophil-to-Lymphocyte Ratio and Adverse Clinical Prognosis in Patients with Spontaneous Intracerebral Hemorrhage
Du Y, Wang A, Zhang J, Zhang X, Li N, Liu X, Wang W, Zhao X, Bian L
Neuropsychiatric Disease and Treatment 2022, 18:985-993
Published Date: 10 May 2022
Clozapine and Neutropenia in Patients with Schizophrenia and SARS-CoV-2 Infection
Moga S, Teodorescu A, Ifteni P, Petric PS, Miron AA
Neuropsychiatric Disease and Treatment 2022, 18:977-983
Published Date: 4 May 2022
A Feasibility Study of Patients with Major Depression and Substance Use Disorders: Vortioxetine as Maintenance Treatment
Basurte-Villamor I, Vega P, Roncero C, Martínez-Raga J, Grau-López L, Aguilar L, Torrens M, Szerman N
Neuropsychiatric Disease and Treatment 2022, 18:965-976
Published Date: 4 May 2022
Efficacy and Safety of Low-Dose Rituximab in Anti-MuSK Myasthenia Gravis Patients: A Retrospective Study
Meng X, Zeng Z, Wang Y, Guo S, Wang C, Wang B, Guo S
Neuropsychiatric Disease and Treatment 2022, 18:953-964
Published Date: 3 May 2022
Elevated Serum Complement C1q Levels After Traumatic Brain Injury [Letter]
Paiva WS, Ortiz J, Amorim RL
Neuropsychiatric Disease and Treatment 2022, 18:951-952
Published Date: 4 May 2022
Serum Calcium Levels and in-Hospital Infection Risk in Patients with Acute Ischemic Stroke
Chen X, Liang X, Zhang J, Chen L, Sun J, Cai X
Neuropsychiatric Disease and Treatment 2022, 18:943-950
Published Date: 3 May 2022
Venous Flow Profiles on Perfusion CT are Associated with Futile Recanalization After Thrombectomy
Su M, Chen Z, Chen X, Huang J, Li Z, Zhou Y, Xu G
Neuropsychiatric Disease and Treatment 2022, 18:933-942
Published Date: 29 April 2022
Correlation Between Refractory Laryngopharyngeal Reflux Disease and Symptoms of Anxiety and Depression
Huang F, Liao Q, Gan X, Wen W
Neuropsychiatric Disease and Treatment 2022, 18:925-932
Published Date: 26 April 2022
Effects of Atorvastatin Therapy on Postoperative Delirium After Malignant Tumor Surgeries in Older Adults
Wan R, Cai S, Pan D, Yang W, Zhou R
Neuropsychiatric Disease and Treatment 2022, 18:915-923
Published Date: 19 April 2022
Correlation Between Plasma High Mobility Group Protein N1 Level and the Prognosis of Patients with Acute Cerebral Infarction: Preliminary Findings
Lin Y, Wang K, Ji D, Gong Z, Wang Z
Neuropsychiatric Disease and Treatment 2022, 18:907-913
Published Date: 19 April 2022
Influence of Pre-Existing Cerebral Small Vessel Disease on the Outcome of Acute Cardioembolic Stroke: A Retrospective Study
Su Y, Guo Y, Chen Z, Zhang M, Liu J, Wang Q, Yao T
Neuropsychiatric Disease and Treatment 2022, 18:899-905
Published Date: 15 April 2022
Relationship Between Cognitive Functions and Decision-Making Capacity in Older Institutionalized Patients with Schizophrenia: A Preliminary Study
Sugawara N, Yasui-Furukori N, Yamada S, Aoki M, Takeuchi Y, Miyazaki K, Shimoda K
Neuropsychiatric Disease and Treatment 2022, 18:891-897
Published Date: 15 April 2022
Study on the Association of Homocysteine and C-Reactive Protein with Neurofunctional Changes in Patients with Acute Ischemic Stroke After Endovascular Stent Treatment
Chen Q, Ling WT, Han DK
Neuropsychiatric Disease and Treatment 2022, 18:881-889
Published Date: 13 April 2022
Practical Advice for Primary Care Clinicians on the Safe and Effective Use of Vortioxetine for Patients with Major Depressive Disorder (MDD)
Montano CB, Jackson WC, Vanacore D, Weisler RH
Neuropsychiatric Disease and Treatment 2022, 18:867-879
Published Date: 12 April 2022
Risk Factors for Depression in Tuberculosis Patients: A Meta-Analysis
Shen R, Zong K, Liu J, Zhang L
Neuropsychiatric Disease and Treatment 2022, 18:847-866
Published Date: 11 April 2022
Effectiveness and Quality of Life with Paliperidone Palmitate 3-Monthly in Comparison with Other Long-Acting Drugs
Di Lorenzo R, Iorio A, Pinelli M, Magarini F, Marchi M, Sacchetti A, Calogero C, Galeazzi GM, Ferri P, Rovesti S, Minarini A
Neuropsychiatric Disease and Treatment 2022, 18:829-846
Published Date: 12 April 2022
Schizophrenia, Bipolar Disorder and Pre-Attentional Inhibitory Deficits
Vlcek P, Bob P
Neuropsychiatric Disease and Treatment 2022, 18:821-827
Published Date: 8 April 2022
Study on the Correlation Between Iris Characteristics and Schizophrenia
Tian C, Duan L, Fu C, He J, Dai J, Zhu G
Neuropsychiatric Disease and Treatment 2022, 18:811-820
Published Date: 8 April 2022
Relationship Between Employment Status and Unstable Periods in Outpatients with Bipolar Disorder: A Multicenter Treatment Survey for Bipolar Disorder in Psychiatric Outpatient Clinics (MUSUBI) Study
Ikenouchi A, Konno Y, Fujino Y, Adachi N, Kubota Y, Azekawa T, Ueda H, Edagawa K, Katsumoto E, Goto E, Hongo S, Kato M, Tsuboi T, Yasui-Furukori N, Nakagawa A, Kikuchi T, Watanabe K, Yoshimura R
Neuropsychiatric Disease and Treatment 2022, 18:801-809
Published Date: 8 April 2022
Hallucinations and Other Psychotic Symptoms in Patients with Borderline Personality Disorder
Belohradova Minarikova K, Prasko J, Holubova M, Vanek J, Kantor K, Slepecky M, Latalova K, Ociskova M
Neuropsychiatric Disease and Treatment 2022, 18:787-799
Published Date: 8 April 2022
Psychometric Evaluation of the Polish Version of the Caregiver Priorities and Child Health Index of Life with Disabilities (CPCHILD)
Nowak P, Narayanan U, Szmurło M, Krzyżańska A, Głowacki M, Misterska E, Jóźwiak M
Neuropsychiatric Disease and Treatment 2022, 18:773-785
Published Date: 7 April 2022
Prevalence and Associated Factors of PTSD Symptoms After the COVID-19 Epidemic Outbreak in an Online Survey in China: The Age and Gender Differences Matter
Mao J, Wang C, Teng C, Wang M, Zhou S, Zhao K, Ye X, Wang Y
Neuropsychiatric Disease and Treatment 2022, 18:761-771
Published Date: 5 April 2022
Swimming Exercise Modulates Gut Microbiota in CUMS-Induced Depressed Mice
Xie Y, Wu Z, Zhou L, Sun L, Xiao L, Wang G
Neuropsychiatric Disease and Treatment 2022, 18:749-760
Published Date: 5 April 2022
Levels of Peripheral Circulating IL-6 and IL-10 Decrease Over Time Despite High Depression Burden in PTSD Patients
Toft H, Bramness JG, Lien L
Neuropsychiatric Disease and Treatment 2022, 18:737-747
Published Date: 5 April 2022
CYP2D6 Gene Polymorphisms and Variable Metabolic Activity in Schizophrenia Patients of Han and Tibetan Populations
Li YH, Huang W, Xiao MY, Huang SQ, Chen H, Li ZF, Li XS, Cheng Y
Neuropsychiatric Disease and Treatment 2022, 18:731-736
Published Date: 2 April 2022
Abnormalities of Gray Matter Volume and Its Correlation with Clinical Symptoms in Adolescents with High-Functioning Autism Spectrum Disorder
Zhao X, Zhu S, Cao Y, Cheng P, Lin Y, Sun Z, Jiang W, Du Y
Neuropsychiatric Disease and Treatment 2022, 18:717-730
Published Date: 1 April 2022
Kinesiophobia in Elderly Polish Patients After Ischemic Stroke, Including Frailty Syndrome
Bąk E, Młynarska A, Marcisz C, Kadłubowska M, Marcisz-Dyla E, Sternal D, Młynarski R, Krzemińska S
Neuropsychiatric Disease and Treatment 2022, 18:707-715
Published Date: 31 March 2022
Awareness of Drug–Drug Interaction in Elderly Patients with Osteoarthritis and Depression [Letter]
Zhu LL, Zhou Q
Neuropsychiatric Disease and Treatment 2022, 18:705-706
Published Date: 1 April 2022
Elevated Red Blood Cell Distribution Width Levels at Admission Predicts Depression After Acute Ischemic Stroke: A 3-Month Follow-Up Study
Li Y, Zhang M, Dong C, Xue M, Li J, Wu G
Neuropsychiatric Disease and Treatment 2022, 18:695-704
Published Date: 31 March 2022
Effect of Early Swimming on the Behavior and Striatal Transcriptome of the Shank3 Knockout Rat Model of Autism
Meng Y, Xu D, Zhang W, Meng W, Lan XY, Wang X, Li M, Zhang X, Zhao Y, Yang H, Zhang R, Zhen Z
Neuropsychiatric Disease and Treatment 2022, 18:681-694
Published Date: 31 March 2022
Clinical Efficacy of the Chinese Herbal Medicine Shumian Capsule for Insomnia: A Randomized, Double-Blind, Placebo-Controlled Trial
Chen S, Xu Z, Li Y, Wang T, Yue Y, Hou Z, You L, Lu N, Yin Y, Liu X, Tan L, Ji H, Shi Y, Xin X, Jiang W, Yuan Y
Neuropsychiatric Disease and Treatment 2022, 18:669-679
Published Date: 29 March 2022
XGBoost Machine Learning Algorithm for Prediction of Outcome in Aneurysmal Subarachnoid Hemorrhage
Wang R, Zhang J, Shan B, He M, Xu J
Neuropsychiatric Disease and Treatment 2022, 18:659-667
Published Date: 29 March 2022
Early Lipid Metabolic Effects of the Anti-Psychotic Drug Olanzapine on Weight Gain and the Associated Gene Expression
Chen CC, Nakano T, Hsu LW, Chu CY, Huang KT
Neuropsychiatric Disease and Treatment 2022, 18:645-657
Published Date: 23 March 2022
Impact of Isolation During the COVID-19 Pandemic on the Patient Burden of Parkinson’s Disease: A PMD Alliance Survey
Hermanowicz N, Ospina MC, Torres-Yaghi Y, Gould S, Papesh K, Rivera JA, Miller S, Jones S, Musick K, May D
Neuropsychiatric Disease and Treatment 2022, 18:633-643
Published Date: 23 March 2022
Developing a Conceptual Disease Model of Patient Experiences and Identifying Patient-Reported Clinical Outcome Assessments for Use in Trials of Treatments for Focal Onset Seizures
Oberdhan D, Bacci E, Hill JN, Palsgrove A, Hareendran A
Neuropsychiatric Disease and Treatment 2022, 18:611-631
Published Date: 22 March 2022
Between Personality Traits and Postpartum Depression: The Mediated Role of Maternal Self-Efficacy
Han L, Zhang J, Yang J, Yang X, Bai H
Neuropsychiatric Disease and Treatment 2022, 18:597-609
Published Date: 19 March 2022
The Association Between the Duration, Treatment, Control of Hypertension and Lifestyle Risk Factors in Middle-Aged and Elderly Patients with Mild Cognitive Impairment: A Case-Control Study
Yan X, Meng T, Liu H, Liu J, Du J, Chang C
Neuropsychiatric Disease and Treatment 2022, 18:585-595
Published Date: 19 March 2022
Fasting Blood-Glucose Level and Clinical Outcome in Anterior Circulation Ischemic Stroke of Different Age Groups After Endovascular Treatment
Yuan L, Sun Y, Huang X, Xu X, Xu J, Xu Y, Yang Q, Zhu Y, Zhou Z
Neuropsychiatric Disease and Treatment 2022, 18:575-583
Published Date: 18 March 2022
Evaluation of White Matter Microstructural Alterations in Patients with Post-Stroke Cognitive Impairment at the Sub-Acute Stage
He C, Gong M, Li G, Shen Y, Han L, Han B, Lou M
Neuropsychiatric Disease and Treatment 2022, 18:563-573
Published Date: 14 March 2022
Amplitude of Low-Frequency Oscillations in First-Episode Drug-Naive Patients with Major Depressive Disorder: A Resting State Functional Magnetic Resonance Imaging Study
Zhang L, Wei X, Zhao J
Neuropsychiatric Disease and Treatment 2022, 18:555-561
Published Date: 8 March 2022
Vitamin B6, B9, and B12 Intakes and Cognitive Performance in Elders: National Health and Nutrition Examination Survey, 2011–2014
Xu H, Wang S, Gao F, Li C
Neuropsychiatric Disease and Treatment 2022, 18:537-553
Published Date: 9 March 2022
Effect of the Minor C Allele of CNTN4 rs2619566 on Medial Hypothalamic Connectivity in Early-Stage Patients of Chinese Han Ancestry with Sporadic Amyotrophic Lateral Sclerosis [Corrigendum]
Wang Y, He Y, Zhu Y, He T, Xu J, Kuang Q, Ji Y, Xu R, Li F, Zhou F
Neuropsychiatric Disease and Treatment 2022, 18:535-536
Published Date: 8 March 2022
Diagnostic Values of Serum Levels of Homocysteine, Heat Shock Protein 70 and High-Sensitivity C-Reactive Protein for Predicting Vascular Cognitive Impairment
Cao L, Sun Z
Neuropsychiatric Disease and Treatment 2022, 18:525-533
Published Date: 8 March 2022
Senegenin Inhibits Aβ1-42-Induced PC12 Cells Apoptosis and Oxidative Stress via Activation of the PI3K/Akt Signaling Pathway
Ren X, Zhang J, Zhao Y, Sun L
Neuropsychiatric Disease and Treatment 2022, 18:513-524
Published Date: 4 March 2022
Prevalence and Consequences of Cerebral Small Vessel Diseases: A Cross-Sectional Study Based on Community People Plotted Against 5-Year Age Strata
Mu R, Qin X, Guo Z, Meng Z, Liu F, Zhuang Z, Zheng W, Li X, Yang P, Feng Y, Jiang Y, Zhu X
Neuropsychiatric Disease and Treatment 2022, 18:499-512
Published Date: 3 March 2022
Role of Calcium Homeostasis in Alzheimer’s Disease
Ge M, Zhang J, Chen S, Huang Y, Chen W, He L, Zhang Y
Neuropsychiatric Disease and Treatment 2022, 18:487-498
Published Date: 3 March 2022
The Index of Esophageal Cancer Related Ischemic Stroke: A Retrospective Patient Control Study
Liu Y, Lu L, Cheng X, Qin Q, Wei Y, Wang D, Li H, Li G, Liang H, Li S, Liang Z
Neuropsychiatric Disease and Treatment 2022, 18:477-485
Published Date: 2 March 2022
Discontinuing Antipsychotic Medication After Remission from First-Episode Psychosis: A Survey of Psychiatrists’ Attitudes in Taiwan
Yen K, Liu CC, Lin YT, Chien YL, Hsieh MH, Liu CM, Hwang TJ, Liao WH, Hwu HG
Neuropsychiatric Disease and Treatment 2022, 18:465-475
Published Date: 1 March 2022
Letter to the Editor Regarding “Fluoxetine May Enhance VEGF, BDNF and Cognition in Patients with Vascular Cognitive Impairment No Dementia: An Open-Label Randomized Clinical Study” [Letter]
Brück CC
Neuropsychiatric Disease and Treatment 2022, 18:463-464
Published Date: 28 February 2022
Cerebrovascular Complications After Adult-Onset Varicella-Zoster Virus Encephalitis in the Central Nervous System: A Literature Review
Wu H, Wang R, Li Y, Sun X, Li J, Bi X
Neuropsychiatric Disease and Treatment 2022, 18:449-462
Published Date: 26 February 2022
Effect of the Minor C Allele of CNTN4 rs2619566 on Medial Hypothalamic Connectivity in Early-Stage Patients of Chinese Han Ancestry with Sporadic Amyotrophic Lateral Sclerosis
Wang Y, He Y, Zhu Y, He T, Xu J, Kuang Q, Ji Y, Xu R, Li F, Zhou F
Neuropsychiatric Disease and Treatment 2022, 18:437-448
Published Date: 25 February 2022
Research Progress in the Study of Startle Reflex to Disease States
Zhang J, Wang M, Wei B, Shi J, Yu T
Neuropsychiatric Disease and Treatment 2022, 18:427-435
Published Date: 24 February 2022
Optimization of an Intranasal Route for the Delivery of Human Neural Stem Cells to Treat a Neonatal Hypoxic-Ischemic Brain Injury Rat Model
Lu S, Li K, Yang Y, Wang Q, Yu Y, Wang Z, Luan Z
Neuropsychiatric Disease and Treatment 2022, 18:413-426
Published Date: 23 February 2022
Effects of Dietary n-3/n-6 PUFA Ratios on Animal Behaviors and Inflammation in a Prenatal Valproic Acid Exposure-Induced Rat Model of Autism
Jia Y, Li P, Wu F, Zeng F, Zhang B, Wang J
Neuropsychiatric Disease and Treatment 2022, 18:401-412
Published Date: 23 February 2022
Interleukin-6 as Predictor of One-Year Cognitive Function After Ischemic Stroke or TIA
Wang Y, Li J, Pan Y, Wang M, Lin J, Meng X, Liao X, Wang Y
Neuropsychiatric Disease and Treatment 2022, 18:391-399
Published Date: 22 February 2022
Depression in Osteoarthritis: Current Understanding
Wang ST, Ni GX
Neuropsychiatric Disease and Treatment 2022, 18:375-389
Published Date: 22 February 2022
Therapeutic Potential of Vortioxetine for Anhedonia-Like Symptoms in Depression: A Post Hoc Analysis of Data from a Clinical Trial Conducted in Japan
Watanabe K, Fujimoto S, Marumoto T, Kitagawa T, Ishida K, Nakajima T, Moriguchi Y, Fujikawa K, Inoue T
Neuropsychiatric Disease and Treatment 2022, 18:363-373
Published Date: 19 February 2022
Use of DWI-FLAIR Mismatch to Estimate the Onset Time in Wake-Up Strokes
Zhang J, Ta N, Fu M, Tian FH, Wang J, Zhang T, Wang B
Neuropsychiatric Disease and Treatment 2022, 18:355-361
Published Date: 21 February 2022
Relationship Between the Hemoglobin-to-Red Cell Distribution Width Ratio and All-Cause Mortality in Ischemic Stroke Patients with Atrial Fibrillation: An Analysis from the MIMIC-IV Database
Qin Z, Liao N, Lu X, Duan X, Zhou Q, Ge L
Neuropsychiatric Disease and Treatment 2022, 18:341-354
Published Date: 18 February 2022
Validation of the Chinese Version of the Autism Diagnostic Interview-Revised in Autism Spectrum Disorder
Huang CF, Lin YS, Chiu YN, Gau SSF, Chen VCH, Lin CF, Hsieh YH, Liu WS, Chan HL, Wu YY
Neuropsychiatric Disease and Treatment 2022, 18:327-339
Published Date: 18 February 2022
Effectiveness and Predictors of Poor Prognosis Following Intravenous Thrombolysis in Patients with Wake-Up Ischemic Stroke Guided by Rapid MRI
Lu Q, Bai Q, Ren H, Zhu B, Jiang T, Peng C, Chen X
Neuropsychiatric Disease and Treatment 2022, 18:317-325
Published Date: 17 February 2022
Stress and Coping in Nurses Taking Care of People Living with HIV in Hunan, China: A Descriptive Qualitative Study
Pan C, Wang H, Chen M, Cai Y, Li P, Xiao C, Tang Q, Koniak-Griffin D
Neuropsychiatric Disease and Treatment 2022, 18:303-315
Published Date: 17 February 2022
Psychometric and Clinical Evaluation of the Clinician (VQIDS-C5) and Self-Report (VQIDS-SR5) Versions of the Very Quick Inventory of Depressive Symptoms
Rush AJ, Madia ND, Carmody T, Trivedi MH
Neuropsychiatric Disease and Treatment 2022, 18:289-302
Published Date: 17 February 2022
Long-Term Functionality Prediction for First Time Ischemic Middle Cerebral Artery Stroke Patients Receiving Conventional Medical Treatment
Yang JL, Lin CM, Hsu YL
Neuropsychiatric Disease and Treatment 2022, 18:275-288
Published Date: 17 February 2022
Victimization in Childhood Influences Presenteeism in Adulthood via Mediation by Neuroticism and Perceived Job Stressors
Hashimoto S, Ichiki M, Ishii Y, Morishita C, Shimura A, Kusumi I, Inoue T, Masuya J
Neuropsychiatric Disease and Treatment 2022, 18:265-274
Published Date: 15 February 2022
Childhood Victimization and Neuroticism Mediate the Effects of Childhood Abuse on Adulthood Depressive Symptoms in Volunteers
Masuya J, Ichiki M, Morishita C, Higashiyama M, Ono M, Honyashiki M, Iwata Y, Tanabe H, Inoue T
Neuropsychiatric Disease and Treatment 2022, 18:253-263
Published Date: 15 February 2022
Relationship Between Sleep Duration and Stroke History in Middle-Aged and Elderly in Guiyang: A Cross-Sectional Survey
Liu L, Yang J, Wang J, Nie M, Wang Z, Guan H, Hu J, Hong F
Neuropsychiatric Disease and Treatment 2022, 18:243-252
Published Date: 11 February 2022
Reduced Peripheral Nerve Conduction Velocity is Associated with Alzheimer’s Disease: A Cross-Sectional Study from China
Qian X, Yue L, Mellor D, Robbins NM, Li W, Xiao S
Neuropsychiatric Disease and Treatment 2022, 18:231-242
Published Date: 11 February 2022
A Nomogram for Individualized Prediction of Stress-Related Gastrointestinal Bleeding in Critically Ill Patients with Primary Intracerebral Hemorrhage
Liu S, Wang Y, Gao B, Peng J
Neuropsychiatric Disease and Treatment 2022, 18:221-229
Published Date: 9 February 2022
Treatment Approaches for First Episode and Early-Phase Schizophrenia in Adolescents and Young Adults: A Delphi Consensus Report from Europe
Correll CU, Fusar-Poli P, Leucht S, Karow A, Maric N, Moreno C, Nordentoft M, Raballo A
Neuropsychiatric Disease and Treatment 2022, 18:201-219
Published Date: 9 February 2022
The Changes of Brain Function After Spinal Manipulation Therapy in Patients with Chronic Low Back Pain: A Rest BOLD fMRI Study
Yang YC, Zeng K, Wang W, Gong ZG, Chen YL, Cheng JM, Zhang M, Huang YW, Men XB, Wang JW, Zhan S, Tan WL
Neuropsychiatric Disease and Treatment 2022, 18:187-199
Published Date: 5 February 2022
Associations of Serum Cytokines, Growth Factors, and High-Sensitivity C-Reactive Protein Levels in Patients with Major Depression with and without Type 2 Diabetes Mellitus: An Explanatory Investigation
Hoshikawa T, Okamoto N, Natsuyama T, Fujii R, Ikenouchi A, Honma Y, Harada M, Yoshimura R
Neuropsychiatric Disease and Treatment 2022, 18:173-186
Published Date: 3 February 2022
The Development of a Suicidal Ideation Predictive Model for Community-Dwelling Elderly Aged >55 Years
Na KS, Geem ZW, Cho SE
Neuropsychiatric Disease and Treatment 2022, 18:163-172
Published Date: 2 February 2022
Lack of Association of FLT3 rs2504235 and Absence of SLITRK1 var321 in Patients with Tic Disorders from Guangdong Province, China
Gao M, Lin H, Li B, Wen J, Wang Y, Zhang Z, Chen W
Neuropsychiatric Disease and Treatment 2022, 18:155-161
Published Date: 2 February 2022
Post COVID-19 Vaccination-Associated Neurological Complications
Assiri SA, Althaqafi RMM, Alswat K, Alghamdi AA, Alomairi NE, Nemenqani DM, Ibrahim ZS, Elkady A
Neuropsychiatric Disease and Treatment 2022, 18:137-154
Published Date: 2 February 2022
Willis Covered Stent for Treating Intracranial Pseudoaneurysms of the Internal Carotid Artery: A Multi-Institutional Study
Lu D, Ma T, Zhu G, Zhang T, Wang N, Lei H, Sui J, Wang Z, He S, Chen L, Deng J
Neuropsychiatric Disease and Treatment 2022, 18:125-135
Published Date: 29 January 2022
Management of Schizophrenia with Long-Acting Injectable Antipsychotic Medications: An Assessment of the Educational Needs of Clinicians
Citrome L, Belcher E, Stacy S, Suett M, Mychaskiw M, Salinas GD
Neuropsychiatric Disease and Treatment 2022, 18:111-123
Published Date: 26 January 2022
Comparison of Current Methods with Neutrophil-to-Lymphocyte Ratio in Predicting Stroke-Associated Pneumonia [Letter]
Zou J, Qiu G
Neuropsychiatric Disease and Treatment 2022, 18:109-110
Published Date: 20 January 2022
Analysis of Factors That Influence the Prognosis of Swallowing Function Rehabilitation Therapy in Patients with Dysphagia After Medullary Infarction
Zhang D, Li Y, Li H, Fu W, Zeng J, Zeng X
Neuropsychiatric Disease and Treatment 2022, 18:97-107
Published Date: 16 January 2022
Translation and Cross-Cultural Adaptation of Post-Stroke Checklist into Mandarin: A Cognitive Interview Study
Jia M, Lu H, Olutoye F, Li J, Huang S, Zhou H
Neuropsychiatric Disease and Treatment 2022, 18:87-95
Published Date: 15 January 2022
Dispositional Mindfulness and Psychotic Symptoms in Schizophrenia Spectrum Disorders: The Mediating Roles of Rumination and Negative Emotion
Lam AHY, Cheung YTD, Wong KH, Leung SF, Chien WT
Neuropsychiatric Disease and Treatment 2022, 18:75-85
Published Date: 11 January 2022
Correlation Between Lacunae and the Wearing-off Phenomenon in Parkinson’s Disease
Zhang M, Chen H, Liu G, Wang X, Wang Z, Feng T, Zhang Y
Neuropsychiatric Disease and Treatment 2022, 18:67-74
Published Date: 11 January 2022
Efficacy of the Jingxin Zhidong Formula for Tic Disorders: A Randomized, Double Blind, Double Dummy, Parallel Controlled Trial
Fan F, Hao L, Zhang S, Zhang Y, Bian Z, Zhang X, Wang Q, Han F
Neuropsychiatric Disease and Treatment 2022, 18:57-66
Published Date: 11 January 2022
Elevated Serum Complement C1q Levels After Traumatic Brain Injury and Its Association with Poor Prognosis
Yan XJ, Li YB, Liu W, Wu HY, Yu GF
Neuropsychiatric Disease and Treatment 2022, 18:47-55
Published Date: 8 January 2022
Schema Therapy for Patients with Bipolar Disorder: Theoretical Framework and Application
Ociskova M, Prasko J, Kantor K, Hodny F, Kasyanik P, Holubova M, Vanek J, Slepecky M, Nesnidal V, Minarikova Belohradova K
Neuropsychiatric Disease and Treatment 2022, 18:29-46
Published Date: 6 January 2022
Comparison of Cognitive Performance and Cardiac Function Between Three Different Rat Models of Vascular Dementia
Wei B, Wu S, Wang Z, Song W, Zhu J
Neuropsychiatric Disease and Treatment 2022, 18:19-28
Published Date: 4 January 2022
A Preliminary Study of Different Treatment Strategies for Anxious Depression
Wang Y, Liu X, Peng D, Wu Y, Su Y, Xu J, Ma X, Li Y, Shi J, Cheng X, Rong H, Fang Y
Neuropsychiatric Disease and Treatment 2022, 18:11-18
Published Date: 4 January 2022
Functional Connectivity Density in the Sensorimotor Area is Associated with Sleep Latency in Patients with Primary Insomnia
Ji B, Dai M, Guo Z, Li J, Cao Y, Zhang Z, Zhang Y, Liu X
Neuropsychiatric Disease and Treatment 2022, 18:1-10
Published Date: 4 January 2022